Status:
RECRUITING
Transcranial Direct Current Stimulation for Depression
Lead Sponsor:
Taipei Veterans General Hospital, Taiwan
Conditions:
Depressive Disorder
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Several studies have shown that tDCS is valuable and safe options to improve depressive symptoms in adult patients . However, regarding the tDCS to treat depression in elderly population, only few stu...
Eligibility Criteria
Inclusion
- Participants who meet the criteria of major depression defined by DSM-5 criteria
- Participants will be non-responders and taking an antidepressant of adequate dose and for ≥4 weeks in the current episode which has not led to sufficient clinical improvement (defined as a minimum level of 2 on the ATHF); or can't tolerate the adverse effects of antidepressant in the current episode
- Ambulatory participants with or without any aiding device
Exclusion
- An urgent risk of suicide or severe depression
- A history of ineffectiveness with tDCS
- People who are clinically contraindicated to receive tDCS intervention or MRI assessment, such as having any brain lesion, intracranial implants (clips, cochlear implants), a tattoo or metal embedded in their scalp or brain
- Any instable medical condition
- A history of epilepsy,
- A history of substance use (within one year)
- People with dementia or psychotic disorder.
- Any condition which would make the subject unsuitable for the study under the physician's assessment.
Key Trial Info
Start Date :
September 8 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06187454
Start Date
September 8 2020
End Date
December 31 2026
Last Update
January 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
TaipeiVGH
Taipei, Taiwan